Girl’s Brain Surgery Stops 20 Daily Seizures | The Children’s Hospital

For years, Anne suffered from debilitating epilepsy, experiencing an average of twenty seizures a day. The condition profoundly impacted her daily life, leading doctors to consider a highly complex surgical intervention: the removal of the brain region responsible for triggering the seizures. Her story highlights the difficult decisions families and medical teams face when conventional treatments fail to control severe epilepsy.

Brain surgery is not undertaken lightly. The brain houses vital functions, and any damage carries the risk of lasting consequences. As neurosurgeon Friso Hoefnagels explained, “Should a blood vessel happen to be damaged or spasm, there is a chance that not enough blood will get through, and Anne could have a very small stroke, which could cause damage where you don’t want it.” This underscores the inherent risks associated with operating on such a delicate organ.

Prior to the definitive surgery, Anne underwent extensive testing to pinpoint the precise area of her brain causing the seizures. This meticulous pre-operative assessment gave the surgical team confidence in proceeding. “We think we can do it safely, without having to worry that she will have a permanent language problem ” the doctor assured Anne’s mother, Christel. This careful planning is crucial in minimizing potential neurological deficits.

The day of the surgery arrived, and while Anne remained remarkably calm – stating, “It’s not scary, because I’ve already had it three times” – her mother experienced growing anxiety. “I do notice that I have tension in my stomach and a little stomach pain,” Christel shared, reflecting the emotional toll on families facing such procedures.

As Anne was prepared for anesthesia and wheeled into the operating room, her parents were left in a state of uncertainty. “Anything can happen on an operating table, especially when you’re operating in the brain. That’s what I find particularly scary,” Christel admitted. This sentiment is common among parents whose children are undergoing major surgery.

Fortunately, the operation proceeded without complications. Post-operatively, doctors detected no further epileptiform activity in Anne’s brain. “It’s so nice. It’s just the best scenario so far,” Christel exclaimed with relief. However, the true success of the procedure will only be determined over time. “If people are seizure-free for a year or two, then the operation is considered successful,” the neurosurgeon noted, emphasizing the need for long-term follow-up.

Just three days after the surgery, Anne was discharged and able to return home. As of the latest reports, she has remained seizure-free and is recovering well. This positive initial outcome offers hope for a significant improvement in her quality of life.

Anne’s case is particularly noteworthy given recent advances in personalized medicine and gene editing therapies for neurological disorders. While her treatment involved traditional surgical intervention, the field of gene therapy is rapidly evolving. May 15, 2025, Children’s Hospital of Philadelphia (CHOP) and Penn Medicine announced the first successful treatment of a child, KJ, with a customized CRISPR gene editing therapy for a rare metabolic disease, severe carbamoyl phosphate synthetase 1 (CPS1) deficiency. This landmark study, published in The New England Journal of Medicine and presented at the American Society of Gene & Cell Therapy Annual Meeting, demonstrates the potential of tailoring gene editing to address specific genetic defects. Although KJ’s condition differs from Anne’s epilepsy, the success highlights the growing possibilities for treating previously untreatable conditions.

advancements in minimally-invasive techniques, such as laser ablation, are also transforming the treatment of epilepsy. Seattle Children’s Hospital has reported success using laser ablation to address elusive forms of epilepsy, even in cases where patients experience more than 60 seizures a day. This approach offers a less invasive alternative to traditional open brain surgery, potentially reducing recovery time and complications.

Epilepsy affects millions worldwide, and while many individuals respond well to medication, a significant proportion experience persistent seizures despite treatment. In these cases, surgical intervention, including resective surgery (removing the seizure focus) and neuromodulation techniques (altering brain activity), may be considered. The choice of treatment depends on the type of epilepsy, the location of the seizure focus, and the patient’s overall health.

The story of a young girl in Ohio, who suffered from 20 seizures a day, also illustrates the impact of epilepsy and the potential benefits of brain surgery. She underwent brain surgery at Cleveland Clinic Children’s Hospital for Rehabilitation, and caregivers reported a significant improvement in her condition. While details are limited, this case further emphasizes the importance of comprehensive epilepsy care.

The future of epilepsy treatment is likely to involve a combination of approaches, including improved medications, advanced surgical techniques, and innovative gene therapies. Continued research and collaboration between medical centers are essential to developing more effective and personalized treatments for individuals living with epilepsy.